Dennis D Kim insider trades: CymaBay Therapeutics (CBAY) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Dennis reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 17, 2023 | CBAY | ↓ Sell | 120,000 | $9.50 | $1.1M | Direct | Apr 17, 2023 (0d) |
| Mar 28, 2023 | CBAY | ↓ Sell | 100 | $8.98 | $899 | Direct | Mar 30, 2023 (2d) |
| Jan 19, 2022 | CBAY | ↑ Buy | 20,000 | $3.04 | $61K | Direct | Jan 20, 2022 (1d) |
| Jul 11, 2017 | ZFGN | ↑ Buy | 10,000 | $3.39 | $34K | Direct | Jul 12, 2017 (1d) |
| May 11, 2017 | ZFGN | ↑ Buy | 10,000 | $4.40 | $44K | Direct | May 11, 2017 (0d) |
| Sep 17, 2015 | ZFGN | ↓ Sell | 39,407 | $40.00 | $1.6M | Direct | Sep 17, 2015 (0d) |
| Sep 14, 2015 | ZFGN | ↓ Sell | 593 | $40.00 | $24K | Direct | Sep 16, 2015 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Dennis D Kim's insider trades
Dennis D Kim is Chief Medical Officer at CymaBay Therapeutics (CBAY). Since Sep 14, 2015, Dennis has reported 3 open-market purchases worth $139K and 4 sales worth $2.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (12 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CBAY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.